Emad F. Eskander

695 citations
31 papers · 550 indexed · h-index 10
Topics
Hepatitis C virus research (7 papers)Liver Disease Diagnosis and Treatment (5 papers)Regulation of Appetite and Obesity (5 papers)
Partner nations
EgyptIndiaCanada

In The Last Decade

Emad F. Eskander

31 papers receiving 523 citations

Peers

Emad F. Eskander
Comparison fields: 5 of 85
  • Molecular Biology 145
  • Cancer Research 104
  • Organic Chemistry 93
  • Oncology 86
  • Pathology and Forensic Medicine 82
Replace Lingyu Li with:
Lingyu Li China
Hideaki Nakamura Japan
Minsun Kim South Korea
Ahmed E. Goda Egypt
Huiying Duan China
Julio Isael Pérez‐Carreón Mexico
Kalpana K. Bhanumathy Canada
K. Kolanjiappan India
Shahanas Chathoth Saudi Arabia
Gehan A. Hegazy Saudi Arabia
Emad F. Eskander relative to Lingyu Li China Lingyu Li's profile →
Citations per field
00.5×4.6×
Lingyu Li · 1×
Citations per year

Countries citing papers authored by Emad F. Eskander

Since Specialization
Citations

This map shows the geographic impact of Emad F. Eskander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emad F. Eskander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emad F. Eskander more than expected).

Fields of papers citing papers by Emad F. Eskander

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emad F. Eskander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emad F. Eskander. The network helps show where Emad F. Eskander may publish in the future.

Co-authorship network of co-authors of Emad F. Eskander

This figure shows the co-authorship network connecting the top 25 collaborators of Emad F. Eskander. A scholar is included among the top collaborators of Emad F. Eskander based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emad F. Eskander. Emad F. Eskander is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 4
2 28
3 1
4 1
5 3
6 1
7 2
8 2
9 9
10 8
11 7
12 55
13 8
14 77
15 2
16 2
17 3
18 1
19 146
20 5

About Emad F. Eskander

Emad F. Eskander is a scholar working on Hepatology, Toxicology and Endocrine and Autonomic Systems, having authored 31 papers that have together received 550 indexed citations. Recurring topics across this work include Hepatitis C virus research (7 papers), Liver Disease Diagnosis and Treatment (5 papers) and Regulation of Appetite and Obesity (5 papers). The work is most often cited by research in Biophysics (47 citations), Cancer Research (104 citations) and Toxicology (17 citations). Emad F. Eskander has collaborated with scholars based in Egypt, India and Canada. Frequent co-authors include Ahmed Abdrabou, Floyd A. Benko, Allan Lipton, MICHAEL S. KOPRESKI, Christopher D. Gocke, Kim Leitzel, Hanaa H. Ahmed, Gamal A. Elmegeed, Josline Y. Salib and Mohamed A. Tantawy. Their work appears in journals such as British Journal of Cancer, Gene and Clinica Chimica Acta.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026